- Home
- ERAS vs MYN Comparison
ERAS vs MYN Comparison
Compare ERAS & MYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- MYN
- Stock Information
- Founded
- ERAS 2018
- MYN 1992
- Country
- ERAS United States
- MYN United States
- Employees
- ERAS N/A
- MYN N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- MYN Finance Companies
- Sector
- ERAS Health Care
- MYN Finance
- Exchange
- ERAS Nasdaq
- MYN Nasdaq
- Market Cap
- ERAS 348.4M
- MYN 371.3M
- IPO Year
- ERAS 2021
- MYN N/A
- Fundamental
- Price
- ERAS $1.36
- MYN $9.52
- Analyst Decision
- ERAS Strong Buy
- MYN
- Analyst Count
- ERAS 6
- MYN 0
- Target Price
- ERAS $4.83
- MYN N/A
- AVG Volume (30 Days)
- ERAS 1.5M
- MYN 86.0K
- Earning Date
- ERAS 05-13-2025
- MYN 01-01-0001
- Dividend Yield
- ERAS N/A
- MYN 4.12%
- EPS Growth
- ERAS N/A
- MYN N/A
- EPS
- ERAS N/A
- MYN N/A
- Revenue
- ERAS N/A
- MYN N/A
- Revenue This Year
- ERAS N/A
- MYN N/A
- Revenue Next Year
- ERAS N/A
- MYN N/A
- P/E Ratio
- ERAS N/A
- MYN N/A
- Revenue Growth
- ERAS N/A
- MYN N/A
- 52 Week Low
- ERAS $1.01
- MYN $8.47
- 52 Week High
- ERAS $3.45
- MYN $10.62
- Technical
- Relative Strength Index (RSI)
- ERAS 54.43
- MYN 44.24
- Support Level
- ERAS $1.06
- MYN $9.44
- Resistance Level
- ERAS $1.47
- MYN $9.63
- Average True Range (ATR)
- ERAS 0.14
- MYN 0.09
- MACD
- ERAS 0.02
- MYN -0.00
- Stochastic Oscillator
- ERAS 70.65
- MYN 31.08
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock
Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.